MAIER PAUL V

CIK 000118261511 companiesDEERPARK, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001182615

Recent Transactions

50 trades

Award
Eton Pharmaceuticals, Inc.$ETON
Employee Stock Option (Right to Buy)
2026-01-12+12,196→ 286,496 total
Award
Eton Pharmaceuticals, Inc.$ETON
Restricted Stock Units
2026-01-12+7,757→ 294,253 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2025-06-17+532,786→ 532,786 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2025-06-17+30,000→ 30,000 total
Award
Eton Pharmaceuticals, Inc.$ETON
Employee Stock Option (Right to Buy)
2025-01-03+25,000→ 25,000 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2024-06-11+361,111→ 361,111 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2024-06-11+30,000→ 30,000 total
Disposition to Issuer
Ambrx Biopharma, Inc.
Option to Purchase Common Stock
2024-03-07−15,000→ 0 total
Disposition to Issuer
Ambrx Biopharma, Inc.
Option to Purchase Common Stock
2024-03-07−30,000→ 0 total
Disposition to Issuer
Ambrx Biopharma, Inc.
Restricted Stock Units
2024-03-07−12,142→ 0 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option (Right to buy)
2024-02-13+30,000→ 164,555 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2023-06-14+445,205→ 445,205 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2023-06-14+30,000→ 30,000 total
Award
Ambrx Biopharma Cayman, Inc.
Ordinary Shares
2023-06-07+85,000→ 85,000 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option(Right to buy)
2023-03-03+25,000→ 134,555 total
Award
Ambrx Biopharma Cayman, Inc.
Stock Option (right to buy)
2023-01-27+105,000→ 105,000 total
Disposition to Issuer
Ambrx Biopharma Cayman, Inc.
Stock Option (right to buy)
2023-01-27−210,000→ 0 total
Award
Ambrx Biopharma Cayman, Inc.
Stock Option (right to buy)
2023-01-27+210,000→ 210,000 total
Disposition to Issuer
Ambrx Biopharma Cayman, Inc.
Stock Option (right to buy)
2023-01-27−105,000→ 0 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2022-06-09+139,264→ 139,264 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2022-06-09+30,000→ 30,000 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option(Right to buy)
2022-02-07+50,000→ 109,555 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2021-06-09+183,481→ 183,481 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2021-06-09+30,000→ 30,000 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option(Right to buy)
2021-05-03+19,655→ 59,555 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2020-06-23+30,000→ 30,000 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2020-06-23+46,428→ 46,428 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2020-06-23+92,857→ 92,857 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option (Right to buy)
2020-03-12+27,400→ 27,400 total
Award
AIxCrypto Holdings, Inc.$AIXC
Non-qualified Stock Option (Right to Buy)
2020-01-15+12,000→ 12,000 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2019-06-03+30,000→ 30,000 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2019-06-03+71,982→ 71,982 total
Sale
International Stem Cell CORP$ISCO
Common Stock
2019-04-18$1.25/sh−1,350→ 31,710 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock option (right to buy)
2019-02-20+12,500→ 12,500 total
Award
AIxCrypto Holdings, Inc.$AIXC
Non-qualified Stock Option (Right to Buy)
2019-02-06+15,000→ 15,000 total
Purchase
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2018-11-15$6.00/sh+5,000→ 59,745 total
Award
International Stem Cell CORP$ISCO
Stock Options (Right to Buy)
2018-06-21+38,462→ 38,462 total
Award
International Stem Cell CORP$ISCO
Stock Options (Right to Buy)
2018-06-21+30,000→ 30,000 total
Award
International Stem Cell CORP$ISCO
Stock Options (Right to Buy)
2018-06-21+8,655→ 8,655 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-04-02+513→ 23,462 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2018-04-02−513→ 0 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-04-02+513→ 23,063 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2018-04-02−513→ 0 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2018-03-30+11,054→ 11,054 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2018-02-21+35,000→ 35,000 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-01-24$0.84/sh−17,999→ 68,314 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-01-23$0.87/sh−17,449→ 86,313 total
Award
AIxCrypto Holdings, Inc.$AIXC
Non-qualified Stock Option (Right to Buy)
2018-01-23+30,000→ 30,000 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2017-12-29+10,350→ 10,350 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2017-10-02+75,790→ 75,790 total

MAIER PAUL V

Recent Transactions

Companies

Recent Filings

Address